Efficacy and safety of monoclonal anti-D immunoglobulin in comparison with polyclonal anti-D immunoglobulin in prevention of rho isoimmunization.
Chauhan
A R
AR
Bhattacharyya
M S
MS
Turakhia
N
N
Daftary
G V
GV
D000209:Acute-Phase Proteins / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D008297:Male; D011247:Pregnancy; D012016:Reference Values; D012203:Rh Isoimmunization / Q000517:prevention & control*; D018029:Rho(D) Immune Globulin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000209:Acute-Phase Proteins; D018029:Rho(D) Immune Globulin